MedPath

Clinical Observation for Yi-Wei Xiao-Yu Granule in Treating Chronic Atrophic Gastritis

Phase 4
Conditions
chronic atrophic gastritis
Registration Number
ITMCTR1900002657
Lead Sponsor
Chongqing Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Accordance to the Vienna Gastrointestinal Epithelial Grading Criteria of Gut 2000, we will include those people who are diagnosed with chronic atrophic gastritis(CAG) between 18-70 years old without gender limitation. Also accordance to the consensus opinion for treatment of chronic gastritis with Chinese medicine(2017) and treatment of CAG(2017) with combination of Chinese and Western medicine. The main symptoms and tongue image are necessary, plus more than 2 secondary symptoms, refer to the tongue and pulse, we will include patients with syndrome of spleen-stomach deficiency.

Exclusion Criteria

Those who have high grade dysplasia, suspicious for gastric cancer or other cancers, stomach operation history and serious system organic disease such as cardiovascular and cerebrovascular diseases, liver, kidney, lung or other system disease; those who are with other syndromes for the consensus opinion for treatment of CAG; those who are taking non-steroidal anti-inflammatory drugs, are pregnant or in lactation period; those who are not willing to take gastroscopy repetition; those who are not willing to sign the consent form.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tissue score, lesion and dysplasia decrease;
Secondary Outcome Measures
NameTimeMethod
Changes of endoscopic score;
© Copyright 2025. All Rights Reserved by MedPath